Final Verdict: Research Comparison Feature Tirzepatide Retatrutide Receptor Targets GLP-1, GIP GLP-1, GIP, Glucagon Half-Life ~5 Days ~6 Days Max Published Weight Loss ~21% (72w) ~24% (48w) Liver Fat Reduction Moderate/High Extreme Primary Research Focus Glycemic Control Metabolic Reset / REE Future Outlook: Post-2025 Research Landscape As we look toward 2026 and beyond, the data from the Phase 3 TRIUMPH trials will likely solidify retatrutides position in the metabolic research hierarchy
My wife is always a challenge to find a vein
Andrew Huberman) were suggesting retatrutide might be muscle sparing, on TV
Its water solubility, chemical modifications, receptor specificity, and enzymatic stability make it ideal for research on obesity, metabolic disorders, and type 2 diabetes
Urinary oxalate concentrations dropped by nearly half at the end of the study (Campieri 2001)